Sibel Health is a Chicago-based digital health company spun out of Northwestern University that builds clinical-grade, fully wireless wearable sensors paired with AI analytics and a cloud platform. Its flagship ANNE One system continuously tracks vital signs - heart rate, respiratory rate, temperature, SpO2, pulse and more - for patients from neonates to adults, in hospitals, at home, and in low-resource settings around the world. The mission is to deliver 'Better Health Data for All.'
William G. Hendren, MD, MBA is the co-founder and CEO of QURA, Inc., a Duxbury, Massachusetts medical technology company building the QSmart platform - an implantable biosensor roughly the size of a grain of rice that continuously measures and wirelessly transmits medical-grade blood pressure data in real time. A surgeon trained at Harvard, Mass General, Emory and the Cleveland Clinic, with an MBA and strategic healthcare consulting experience at PwC across the US, Middle East, China and the UK, Hendren is taking aim at hypertension, which he calls the single leading healthcare threat in the world.
Dave Icke is the CEO of Medisafe, the medication engagement platform that helps more than ten million patients stay on their treatments. A chemical engineer turned digital-health operator, he has spent two decades turning hardware and software into tools that keep people healthier: founding CEO of wearable biosensor company mc10, launcher of Becton Dickinson's digital health business, VP of Digital Health Product at Humana, and executive chair of mental-health AI company ieso. In 2025 he took the reins at Medisafe from founder Omri Shor to scale medication engagement across the global pharmaceutical ecosystem.
Michael (Mike) J. McShane is a biomedical engineer who has spent close to 25 years trying to put readable chemistry under the skin. As James J. Cain Professor II and head of the Department of Biomedical Engineering at Texas A&M University, he builds injectable, biomaterials-based optical biosensors - often called 'smart tattoos' - that glow in response to glucose, oxygen and other body chemistries so doctors can monitor patients continuously and minimally invasively. A Fellow of IEEE, SPIE, BMES and AIMBE, past president of the IEEE Sensors Council and founding chair of the IEEE BioSensors conference, he won the 2012 NIH Director's Transformative Research Award and the 2023 IEEE Sensors Council Technical Achievement Award.
Po-Jui 'Ray' Chiu is CEO and Co-Founder of Calyx (formerly BioInspira), a Berkeley-based agtech company that brings AI vision and bio-engineered phage sensors to poultry and livestock farming. A Forbes 30 Under 30 Energy honoree (2019), Chiu built his company out of a UC Berkeley capstone project and a personal brush with disaster - the 2014 Kaohsiung gas explosions that threatened his relatives' neighborhood in Taiwan. Today, Calyx's AI Eye camera system predicts chicken weights at 98.4% accuracy across 17+ million birds, while its Y-Series sensors monitor ammonia, CO2, temperature, and humidity in real time.